{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:33:02Z","timestamp":1780457582561,"version":"3.54.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC81772235"],"award-info":[{"award-number":["NSFC81772235"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["13ZR1449700"],"award-info":[{"award-number":["13ZR1449700"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Pujiang Talent Program","award":["17PJD004"],"award-info":[{"award-number":["17PJD004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess the in vitro activities of acetylmidecamycin, a 16-membered macrolide, and 11 other antimicrobial agents against human mycoplasmas.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 187 clinical isolates, Mycoplasma pneumoniae (n\u2009=\u2009110), Mycoplasma hominis (n\u2009=\u200926) and Ureaplasma species (n\u2009=\u200951), were included in this study. The MICs of 12 antimicrobial agents, including acetylmidecamycin, thiamphenicol, chloramphenicol and some other macrolides, fluoroquinolones and tetracyclines, for these clinical isolates were determined by the broth microdilution method.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>For M. pneumoniae, the MIC90 values of the tested macrolides were: acetylmidecamycin (1\u2009mg\/L)&amp;lt;josamycin (4\u2009mg\/L)&amp;lt;midecamycin (8\u2009mg\/L)&amp;lt;azithromycin (16\u2009mg\/L)&amp;lt;erythromycin (&amp;gt;128\u2009mg\/L). Thiamphenicol and chloramphenicol had the same MIC90 (2\u2009mg\/L). For Ureaplasma species, the MIC90 values were: acetylmidecamycin (0.25\u2009mg\/L)&amp;lt;josamycin (0.5\u2009mg\/L)=midecamycin&amp;lt;azithromycin (1\u2009mg\/L)=erythromycin. Chloramphenicol had a lower MIC90 (2\u2009mg\/L) than that of thiamphenicol (4\u2009mg\/L). For M. hominis, the MIC90 values were: acetylmidecamycin (0.25\u2009mg\/L)&amp;lt;josamycin (0.5\u2009mg\/L)&amp;lt;midecamycin (2\u2009mg\/L)&amp;lt;azithromycin (&amp;gt;128\u2009mg\/L)=erythromycin. The MIC90 values of chloramphenicol and thiamphenicol were 2 and 4\u2009mg\/L, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The results indicated that acetylmidecamycin and thiamphenicol are active in vitro against the most common mycoplasma species infecting humans, including those resistant to macrolides and fluoroquinolones. Acetylmidecamycin and thiamphenicol might be a promising option for clinicians to treat infections caused by Mycoplasma and Ureaplasma spp., particularly macrolide-resistant M. pneumoniae in paediatrics and fluoroquinolone-resistant M. hominis in adults. Further investigation of their clinical roles in treating infections caused by these organisms is warranted.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkaa027","type":"journal-article","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T20:09:04Z","timestamp":1579291744000},"page":"1513-1517","source":"Crossref","is-referenced-by-count":11,"title":["In vitro activities of acetylmidecamycin and other antimicrobials against human macrolide-resistant Mycoplasma pneumoniae isolates"],"prefix":"10.1093","volume":"75","author":[{"given":"Na","family":"Wang","sequence":"first","affiliation":[{"name":"Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China and Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, 12 Urumqi Middle Road, Jing\u2019 an District, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunheng","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Shanghai Corps Hospital of Chinese People\u2019s Armed Police, 831 Hong Xu Road, Changning District, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Shanghai Children\u2019s Hospital, Shanghai Jiaotong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"first","affiliation":[{"name":"Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China and Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, 12 Urumqi Middle Road, Jing\u2019 an District, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"key":"2020051504583441800_dkaa027-B1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/CMR.17.4.697-728.2004","article-title":"Mycoplasma pneumoniae and its role as a human pathogen","volume":"17","author":"Waites","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"2020051504583441800_dkaa027-B2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma pneumoniae from the respiratory tract and beyond","volume":"30","author":"Waites","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"2020051504583441800_dkaa027-B3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/CMR.18.4.757-789.2005","article-title":"Mycoplasmas and ureaplasmas as neonatal pathogens","volume":"18","author":"Waites","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"2020051504583441800_dkaa027-B4","doi-asserted-by":"crossref","first-page":"1890.","DOI":"10.3389\/fmicb.2019.01890","article-title":"In vitro activities of nemonoxacin and other antimicrobial agents against human Mycoplasma and Ureaplasmas isolates and their defined resistance mechanisms","volume":"10","author":"Wang","year":"2019","journal-title":"Front Microbiol"},{"key":"2020051504583441800_dkaa027-B5","first-page":"289","volume-title":"Mollicutes Molecular Biology and Pathogenesis","author":"Waites","year":"2014"},{"key":"2020051504583441800_dkaa027-B6","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/infdis\/173.6.1445","article-title":"Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients","volume":"173","author":"Ieven","year":"1996","journal-title":"J Infect Dis"},{"key":"2020051504583441800_dkaa027-B7","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1093\/clinids\/17.Supplement_1.S148","article-title":"Detection of Ureaplasma urealyticum by polymerase chain reaction in the urogenital tract of adults, in amniotic fluid, and in the respiratory tract of newborns","volume":"17 Suppl 1","author":"Blanchard","year":"1993","journal-title":"Clin Infect Dis"},{"key":"2020051504583441800_dkaa027-B8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF01709369","article-title":"Polymerase chain reaction versus culture for detection of Ureaplasma urealyticum and Mycoplasma hominis in the urogenital tract of adults and the respiratory tract of newborns","volume":"15","author":"Abele-Horn","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020051504583441800_dkaa027-B9","year":"2011"},{"key":"2020051504583441800_dkaa027-B10","doi-asserted-by":"crossref","first-page":"e02008","DOI":"10.1128\/AAC.02008-16","article-title":"In vitro activities of lefamulin and other antimicrobial agents against macrolide-susceptible and macrolide-resistant Mycoplasma pneumoniae from the United States, Europe, and China","volume":"61","author":"Waites","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2020051504583441800_dkaa027-B11","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1128\/AAC.01684-08","article-title":"Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China","volume":"53","author":"Liu","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2020051504583441800_dkaa027-B12","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1128\/AAC.01349-08","article-title":"Concurrent titration and determination of antibiotic resistance in Ureaplasma species with identification of novel point mutations in genes associated with resistance","volume":"53","author":"Beeton","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2020051504583441800_dkaa027-B13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1128\/AAC.00779-07","article-title":"Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia","volume":"52","author":"Morozumi","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2020051504583441800_dkaa027-B14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/1120009X.1990.11739049","article-title":"Miocamycin distribution in tonsillar and pulmonary tissues after repeated administration","volume":"2","author":"Scaglione","year":"1990","journal-title":"J Chemother"},{"key":"2020051504583441800_dkaa027-B15","doi-asserted-by":"crossref","first-page":"E20.","DOI":"10.3390\/antibiotics5020020","article-title":"Chloramphenicol derivatives as antibacterial and anticancer agents: historic problems and current solutions","volume":"5","author":"Dinos","year":"2016","journal-title":"Antibiotics (Basel)"},{"key":"2020051504583441800_dkaa027-B16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1179\/joc.2002.14.6.554","article-title":"In vitro activity of thiamphenicol against multiresistant Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in Italy","volume":"14","author":"Marchese","year":"2002","journal-title":"J Chemother"},{"key":"2020051504583441800_dkaa027-B17","doi-asserted-by":"crossref","first-page":"e01104","DOI":"10.1128\/AAC.01104-17","article-title":"Antibacterial resistance in Ureaplasma species and Mycoplasma hominis isolates from urine cultures in college-aged females","volume":"61","author":"Valentine-King","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2020051504583441800_dkaa027-B18","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1128\/AAC.00671-16","article-title":"Antimicrobial susceptibility and clonality of clinical Ureaplasma isolates in the United States","volume":"60","author":"Fern\u00e1ndez","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2020051504583441800_dkaa027-B19","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1093\/jac\/dky238","article-title":"Tetracycline and fluoroquinolone resistance in clinical Ureaplasma spp. and Mycoplasma hominis isolates in France between 2010 and 2015","volume":"73","author":"Meygret","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2020051504583441800_dkaa027-B20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1099\/jmm.0.000913","article-title":"Investigation of fluoroquinolone resistance mechanism in Mycoplasma hominis isolated from urogenital samples in a Chinese hospital","volume":"68","author":"Zhang","year":"2019","journal-title":"J Med Microbiol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/6\/1513\/33213979\/dkaa027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/75\/6\/1513\/33213979\/dkaa027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T20:30:02Z","timestamp":1589661002000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/75\/6\/1513\/5740615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,19]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,2,19]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa027","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2020,2,19]]}}}